The present invention relates to the administration of Keratinocyte Growth Factor-2 to stimulate proliferation of platelets and to increase levels of fibrinogen, albumin, globulin and total serum protein. The system includes a data collection agent 204 configured to identify a first set of routers from among a larger, second set of routers in an enterprise network, contact each of the routers in the first set of routers but not each of the other routers in the second set of routers, and load network information maintained by at least some of the contacted routers in the first set of routers. The flux also provides a shielding function, thereby eliminating the need for an inert cover gas. In one embodiment, the fixation device is optimized for construction from a biocompatible metal such as titanium, and the proximal anchor is removable to permit removal of the fixation device.